Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment

This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment provides detailed technical information on the human health, environmental and value assessments of picarbutrazox and VAYANTIS Seed Treatment.

Données et ressources

Info additionnelle

Champ Valeur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward